A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing
Clinical trial NCT05857930 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05857930
- Sponsor
- OM Pharma SA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2026-09-30
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.